These press releases are intended for business journalists and analysts/investors
GSK is honoured to be ranked as #1 on FORTUNE's Change the World list.
Access to human papillomavirus (HPV) vaccination could help to protect the health of millions of women in China at risk from exposure to Human Papillomavirus, the major cause of cervical cancer
GSK Institute for Infectious Diseases and Public Health to partner with Tsinghua University to tackle global public health challenges
GSK today announced a Memorandum of Understanding Agreement between the GSK Institute for Infectious Diseases and Public Health and Tsinghua University School of Medicine (Tsinghua). This 5 year public-private partnership will take on public health challenges in China and globally through scientific and talent exchange as well as joint research programs.